Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole for Prevention of NSAID-Associated Ulcers
NCT00595517Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2007
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of esomeprazole in gastric ulcer and duodenal ulcer, sponsored by AstraZeneca. Primary endpoint: Number of Participants Without Gastric and/or Duodenal Ulcer Throughout the Treatment Period at 52 weeks. Started Oct 2007; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastric ulcerduodenal ulcer
Beyond the preview
Go deeper on NCT00595517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00595517.